Drug
Placebo Colchicine
Placebo Colchicine is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_4
1
25%
Ph phase_3
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
3(75.0%)
Phase 4Post-market surveillance
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Not yet recruiting2
Completed2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 33 (75.0%)
Phase 41 (25.0%)
Trials by Status
not_yet_recruiting250%
completed250%
Recent Activity
0 active trials
Showing 4 of 4
not_yet_recruitingphase_4
Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke
NCT06396858
not_yet_recruitingphase_3
Colchicine for Secondary Prevention After Ischemic Stroke (CHANCE-3 EX)
NCT07035405
completedphase_3
Colchicine in High-risk Patients With Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3)
NCT05439356
completedphase_3
Colchicine For Prevention of Perioperative Atrial Fibrillation in Patients Undergoing Thoracic Surgery Pilot Study
NCT01985425
Clinical Trials (4)
Showing 4 of 4 trials
NCT06396858Phase 4
Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke
NCT07035405Phase 3
Colchicine for Secondary Prevention After Ischemic Stroke (CHANCE-3 EX)
NCT05439356Phase 3
Colchicine in High-risk Patients With Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3)
NCT01985425Phase 3
Colchicine For Prevention of Perioperative Atrial Fibrillation in Patients Undergoing Thoracic Surgery Pilot Study
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4